Ibicuruzwa bya Shimi Sarms Pharmaceutical Hagati API Ibikoresho bito SR9009 CAS 1379686-30-2 kubibazo byo gusinzira

SR9009 CAS 1379686-30-2 Ibisobanuro ：

SR 9009 ni synthique REV-ERB agonist igenga imyitwarire ya circadian na metabolism;ifite ubushobozi bwo kuvura indwara ziterwa no gusinzira n'indwara ziterwa na metabolike.Nibintu byayobora icyiciro gishya cyimiti ya kanseri ifitanye isano nisaha yumubiri.
Kugeza ubu, nta ngaruka mbi zatewe na SR9009.Birashobora noneho kuvugwa neza ko inyongera ari nziza cyane kuyikoresha.SR9009 ntabwo ihindura imisemburo muburyo ubwo aribwo bwose ntishobora rero guhumeka muri estrogene, kandi ntishobora guhagarika umusaruro wa testosterone.Kimwe nibindi byongeweho nka SARMS, SR9009 ntabwo ishyira uburozi mumwijima, nubwo bikenewe ko habaho inyongera zimwe zifasha umwijima mugihe uyikoresheje.Capsules 3 kugeza 5 ya N2Guard ifatwa burimunsi izafasha nkimpyiko numwijima.
SR9009, izwi kandi nka Stenabolic, nibiyobyabwenge byubushakashatsi nka agonist wa REV-ERB.
REV-ERB-α na REV-ERB-β, ibyakira bibiri bya kirimbuzi, bifite uruhare runini muguhuza imvugo ya proteine ​​yibanze yisaha itwara injyana mubikorwa na metabolism.